Abstract
Background
Hypofractionated adjuvant radiotherapy (RT) in breast cancer patients treated by conservative surgery has been increasingly used in recent years. We present our experience regarding tolerance/acute toxicity of a hypofractionated RT schedule.
Methods and materials
We report on 339 patients treated for 4 years (March 2003–2007) by 42.5 Gy/16 fractions at the RT Department of Larissa University Hospital. Electron boost of 9–10 Gy/3–4 fractions was given to 104/339 (31%). Axillary/supraclavicular RT was given to the node-positive patients with the same fractionation schedule. Median follow-up time was 24 months.
Results
RTOG grades 0, 1, 2, 3, and 4 for acute skin toxicity were 9.7, 68.7, 17.5, 4, and 0.3%, respectively. Radiation pneumonitis (resolved promptly by steroids) was suspected/diagnosed in 11/339 (3.2%). A total of 8/11 had been treated by regional lymphatics RT. In the univariate analysis, the following variables were examined as predictive of skin (grade >1) and lung (any grade) reactions: age, chemotherapy, endocrine treatment, RT of regional lymphatics, and boost RT. The only significant correlation was that of radiation pneumonitis and RT of regional lymphatics (Fisher’s exact test, P = 0.000).
Conclusion
Our current results are similar to those from other centers, although they need to be evaluated for a longer time. This fractionation seems to be effective with acceptable side effects, while it facilitates the treatment for both patients and RT centers.
Similar content being viewed by others
References
Whelan T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143–50.
Magee B, Swindell R, Harris M, Banerjee SS. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol. 1996;39:223–7.
Ribeiro GG, Magee B, Swindell R, et al. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol. 1993;5:278–83.
McBain CA, Young EA, Swindell R, Magee B, Stewart AL. Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome. Clin Oncol. 2003;15:25–31.
The START Trialists’ Group. The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331–41.
The START Trialists’ Group. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.
Fujii O, Hiratsuka J, Nagase N, et al. Whole breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary results. Breast Cancer. 2008;15:86–92.
Olivotto IA, Weir LM, Kim-Sing C, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol. 1996;41:7–13.
Ahs DV, Benson EA, Sainsbury JR, Round C, Head C. Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire breast cancer group. J Clin Oncol. 1995;7:93–6.
Livi L, Stefanacci M, Scoccianti S, et al. Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. Clin Oncol. 2007;19:120–4.
Plataniotis GA, Theofanopoulou M, Sotiriadou K, et al. High resolution computed tomography findings on the lung of early breast-cancer patients treated by postoperative breast irradiation with a hypofractionated radiotherapy schedule. Indian J Cancer. 2005;42:191–6.
Cox J, Stetz J, Pajak T. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.
Whelan T, Marcellus D, Clark RM, Levine M. Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario. Can Med Assoc J. 1993;149:1273–7.
Holli K, Pitkaenen M, Jarvepnaa R, et al. Early skin and lung reactions in breast cancer patients after radiotherapy: prospective study. Radiother Oncol. 2002;64:163–9.
Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21:355–60.
Price A, Jack WJ, Kerr GR, Rodger A. Acute radiation pneumonitis after postmastectomy irradiation: effect of fraction size. Clin Oncol (R Coll Radiol). 1990;2:224–9.
Lind PARM, Svane G, Gagliardi G, Svensson C. Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:489–96.
Lund MB, Myhre KI, Melsom H, et al. The effect on pulmonary function of tangential field technique in radiotherapy for carcinoma of the breast. Br J Radiol. 1991;64:520–3.
Schratter-Sehn AU, Schurawitzki H, Zach M, et al. High resolution computed tomography of the lungs in irradiated breast cancer patients. Radiother Oncol. 1993;27:198–202.
Ooi GC, Kwong DL, Ho JC, et al. Pulmonary sequelae of treatment for breast cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2001;50:411–9.
Ooi CG, Kwong DLW, Chan KN, Ngan H, Lock DTW, Lam WK, et al. Serial HRCT changes after three-field radiation treatment of breast cancer. Clin Radiol. 2000;55:817–24.
Bentzen SM, Skozylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst. 1996;88(13):918–22.
Moody AM, Mayles WPM, Bliss JM, et al. The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol. 1994;33:106–12.
Dewar JA, Benhamou S, Benhamou E, et al. Cosmetic results following lumpectomy, axillary dissection, radiotherapy for breast cancers. Radiother Oncol. 1988;12:273–80.
Van Limbergen E, Rijnders A, van der Schueren E, et al. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules, surgical treatment techniques on cosmetic results. Radiother Oncol. 1989;16:253–67.
Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W. A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;47:1219–28.
Yarnold J, Bloomfield D, LeVay J, et al. Prospective randomised trial testing 5.7 Gy and 6.0 Gy fractions of whole breast radiotherapy in women with early breast cancer (FAST) trial. Clin Oncol. 2004;16:S30.
Martin S, Mannino M, Rostom A, et al. Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer. Clin Oncol. 2008;20:502–5.
Fisher J, Scott C, Stevens R, et al. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: radiation therapy oncology group (RTOG) 97-13. Int J Radiat Oncol Biol Phys. 2000;48:1307–10.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Plataniotis, G.A., Theofanopoulou, MA., Sotiriadou, K. et al. Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results. Breast Cancer 17, 42–47 (2010). https://doi.org/10.1007/s12282-009-0102-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-009-0102-3